A programmable microfluidic cell array for combinatorial drug screening

Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells

(2011) David J Taylor et al.   BMC CANCER

New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety

(2011) Himisha Beltran et al.   EUROPEAN UROLOGY

An integrated microfluidic device for two-dimensional combinatorial dilution

(2011) Yun-Ho Jang et al.   LAB ON A CHIP

Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists

(2010) Sutapa Barua et al.   CANCER LETTERS

Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancers

(2010) Tatsuhiro Ohgami et al.   CANCER SCIENCE

Microfluidic cell culture systems for drug research

(2010) Min-Hsien Wu et al.   LAB ON A CHIP

Pressure-driven perfusion culture microchamber array for a parallel drug cytotoxicity assay

(2008) Shinji Sugiura et al.   BIOTECHNOLOGY AND BIOENGINEERING

A cell-based high-throughput screen to identify synergistic TRAIL sensitizers

(2008) Nancy Lynn Booth et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY